Matthew R Schwartz
Overview
Explore the profile of Matthew R Schwartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pena J, Schwartz M, Hernandez-Vallant A, Sanchez G
J Behav Med
. 2023 Jan;
46(1-2):129-139.
PMID: 36652085
Latino, Black, American Indian/Alaska Native (AI/AN), and Native Hawaiian or Other Pacific Islander people have the highest hospitalizations and death rates from COVID-19. Social inequalities have exacerbated COVID-19 related health...
2.
Khan E, Kaphingst K, Meyer White K, Sussman A, Guest D, Schofield E, et al.
J Community Genet
. 2021 Nov;
13(1):113-119.
PMID: 34797550
Few studies have examined comprehension and miscomprehension of genetic risk feedback for moderate-risk genes in the general population. We examined the prevalence and nature of accurate and inaccurate genetic risk...
3.
Banerjee S, Sussman A, Schofield E, Guest D, Dailey Y, Schwartz M, et al.
J Health Commun
. 2021 Oct;
26(8):576-585.
PMID: 34612176
Family communication about skin cancer risk may motivate protective behaviors. However, it is unclear how widespread such communication might be. In this study, we describe prevalence and patterns (across environmental,...
4.
Riley K, Sussman A, Schofield E, Guest D, Dailey Y, Schwartz M, et al.
Med Decis Making
. 2021 Aug;
42(3):398-403.
PMID: 34455851
Introduction: Moving beyond numeric representations of risk perceptions, we examine cognitive causation, or superstitious thinking, and negative affect in risk as predictors of (i.e., moderate v. high risk) skin cancer...
5.
Hay J, Kaphingst K, Buller D, Schofield E, Meyer White K, Sussman A, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439206
Public availability of genetic information is increasing; thus, efforts to improve diversity in basic and translational research in genomics is a top priority. Given the increasing U.S. incidence and mortality...
6.
Kaphingst K, Khan E, Meyer White K, Sussman A, Guest D, Schofield E, et al.
Patient Educ Couns
. 2020 Aug;
104(1):12-19.
PMID: 32773237
Objective: Few studies have examined how health literacy impacts responses to genetic information. Methods: We examined this issue among 145 English or Spanish-speaking adult primary care patients enrolled in a...
7.
White K, Dailey Y, Guest D, Zielaskowski K, Robers E, Sussman A, et al.
Cancer Epidemiol Biomarkers Prev
. 2019 Sep;
28(11):1853-1856.
PMID: 31488411
Background: The Melanocortin 1 Receptor () contributes to pigmentation, an important risk factor for developing melanoma. Evaluating SNPs in and association with race/ethnicity, skin type, and perceived cancer risk in...
8.
Hay J, Meyer White K, Sussman A, Kaphingst K, Guest D, Schofield E, et al.
Public Health Genomics
. 2019 Aug;
22(1-2):58-68.
PMID: 31437847
Background: Translational research in genomics has limited reach and requires efforts to broaden access and utility in diverse populations. Skin cancer is common and rates are rising, including among Hispanics....
9.
Joshi P, Rymowicz R, Kennedy C, Schwartz M
Asian J Psychiatr
. 2019 May;
43:65-66.
PMID: 31085439
No abstract available.
10.
Hay J, Berwick M, Zielaskowski K, White K, Rodriguez V, Robers E, et al.
JMIR Res Protoc
. 2017 Apr;
6(4):e52.
PMID: 28442450
Background: Limited translational genomic research currently exists to guide the availability, comprehension, and appropriate use of personalized genomics in diverse general population subgroups. Melanoma skin cancers are preventable, curable, common...